Excelsior Medical Co., Ltd. (TPE:4104)
85.60
-0.20 (-0.23%)
May 29, 2025, 1:30 PM CST
Excelsior Medical Revenue
Excelsior Medical had revenue of 2.15B TWD in the quarter ending March 31, 2025, with 5.25% growth. This brings the company's revenue in the last twelve months to 8.65B, up 4.56% year-over-year. In the year 2024, Excelsior Medical had annual revenue of 8.54B with 3.71% growth.
Revenue (ttm)
8.65B
Revenue Growth
+4.56%
P/S Ratio
1.62
Revenue / Employee
62.65M
Employees
138
Market Cap
13.99B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 8.54B | 305.14M | 3.71% |
Dec 31, 2023 | 8.23B | 1.05B | 14.56% |
Dec 31, 2022 | 7.19B | 613.68M | 9.34% |
Dec 31, 2021 | 6.57B | -102.34M | -1.53% |
Dec 31, 2020 | 6.68B | 218.13M | 3.38% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 11.34B |
Caliway Biopharmaceuticals | 40.47M |
Bora Pharmaceuticals Co., LTD. | 20.87B |
Lotus Pharmaceutical | 19.12B |
Polaris Group | 87.67M |
Oneness Biotech | 117.33M |
Center Laboratories | 1.63B |
Lumosa Therapeutics | 43.59M |